Interview: Daniel Dereser – CEO, Boiron Canada

Boiron Canada is the sixth largest affiliate of Boiron’s global operations (in terms of sales), and under Daniel Dereser’s leadership, the company intends to change the perception of homeopathic medicine in Canada, providing a more informed choice to patients. The CEO touches on global homeopathic trends, the stable family environment at Boiron, and the diverse Canadian talent pool. Daniel, congratulations on 30 years of operations in Canada. Can you provide our international readers with an overview of Boiron’s Canadian activities?
"We are advancing into the right direction, and because of Health Canada’s desire to improve the system, I believe that we will see progress ultimately."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report